VC Sofinnova appoints new parter
This article was originally published in Scrip
Executive Summary
Sofinnova Partners, a Paris-based life science venture capital firm, has named Henrijette Richter a partner. Ms Richter joins Sofinnova from Novo Seeds, part of Novo A/S, which she co-established. She has also invested in and serves on the boards of several biotech companies such as Affinicon, Orphazyme, EpiTherapeutics, Avilex Pharma, and Lysogene.